Showing results (201-210 of 216) with videos related to
Sort By:
Pageof 22
European Urology|November 19, 2004
Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladderA Haferkamp, B Schurch, A Reitz, et al.Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|March 5, 2008
[Embryonal germ cells and germ cell tumors]K Biermann, L C Heukamp, D Nettersheim, et al.British Journal of Cancer|January 10, 2013
Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patientsN Wagener, J Bulkescher, S Macher-Goeppinger, et al.Der Urologe. Ausg. A|January 15, 2009
[Complete resection of urothelial cancer metastases with curative intent]J Lehmann, H Suttmann, P Albers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2004
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)J Atzpodien, H Kirchner, U Jonas, et al.British Journal of Cancer|August 16, 2006
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)J Atzpodien, H Kirchner, U Rebmann, et al.British Journal of Urology|July 17, 1998
Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. MUSE Study GroupG Williams, C C Abbou, E T Amar, et al.British Journal of Urology|January 12, 1999
The effect of transurethral alprostadil on the quality of life of men with erectile dysfunction, and their partners. MUSE Study GroupG Williams, C C Abbou, E T Amar, et al.Der Urologe. Ausg. A|October 6, 2010
[Patients with bladder cancer in clinical stage T2 : survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens]M May, H-M Fritsche, S Brookman-May, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 31, 2012
External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladderP Nuhn, M May, H-M Fritsche, et al.Pageof 22